Changes in the vasodilatory response to methyl-nicotinate in response to S-citalopram [escitalopram] treatment in social phobia patients.
Phase of Trial: Phase II
Latest Information Update: 29 Oct 2013
At a glance
- Drugs Escitalopram (Primary)
- Indications Social phobia
- Focus Therapeutic Use
- 28 Jul 2011 Planned end date changed from 1 Dec 2009 to 1 Oct 2011 as reported by ClinicalTrials.gov.
- 28 Jul 2011 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 03 Jul 2007 New trial record.